Can’t find what you’re looking for? Just contact us and we’ll get back to you.
Empower your organization with a suite of forecasting tools designed to enhance decision-making and refine your commercial strategy.
Discover >
Streamline your business development and licensing strategies with actionable insights and informed decision making, supported by gold-standard data.
Enhance asset management with powerful tools that enable data-driven decisions and optimize your portfolio strategy for sustainable growth.
Stay ahead of the competition by leveraging competitive intelligence solutions to monitor market trends, anticipate competitor actions, and make strategic data-driven decisions.
Size markets, pressure-test assumptions, and build stronger client recommendations with trusted pharma and biotech forecasts, sales data, and therapy area intelligence.
Identify high-potential biopharma opportunities, strengthen pitches, and bring sharper market evidence into every client conversation.
Support client strategy across pipeline assessment, asset prioritization, launch planning, and long-term portfolio growth with evidence that your teams can defend.
Track competitor moves, regulatory shifts, market dynamics, and emerging trends so your teams can advise clients with greater speed, clarity and confidence.
Build sharper valuation narratives for pharma and biotech M&A, IPOs and capital raising with trusted market data, forecasts, and evidence-backed insight.
Screen emerging pharma and biotech opportunities, assess asset potential, and track the market signals that could shape portfolio growth.
Assess pharma and biotech targets, pressure-test commercial assumptions, and support diligence with trusted market, product and competitor intelligence.
Track catalysts, forecast revisions, regulatory events, and competitive shifts that could affect pharma and biotech company valuations.
World Preview 2026 Webinar
2026 Preview
Obesity and GLP-1 Dealmaking: Strategic Trends and Market Signals
How AI is transforming forecasting in pharma
Portfolio Tactics to Scale the $300bn Patent Cliff
Changing Pharma: What’s Reshaping the Industry
Get in touch with our team to explore the right solutions for your business.
